Effect of internal limiting membrane peeling on visual field sensitivity in eyes with epiretinal membrane accompanied by glaucoma with hemifield defect and myopia.


Journal

Japanese journal of ophthalmology
ISSN: 1613-2246
Titre abrégé: Jpn J Ophthalmol
Pays: Japan
ID NLM: 0044652

Informations de publication

Date de publication:
May 2021
Historique:
received: 29 05 2020
accepted: 03 12 2020
pubmed: 4 2 2021
medline: 19 8 2021
entrez: 3 2 2021
Statut: ppublish

Résumé

To investigate the effects of internal limiting membrane (ILM) peeling on visual field sensitivities in eyes with epiretinal membrane (ERM) accompanied by glaucoma with hemifield defect and myopia. Retrospective clinical study METHODS: We reviewed clinical records of patients with ERM who underwent vitrectomy and ERM/ILM peeling. We first collected clinical data of eyes with ERM and glaucoma with hemifield defect. We recorded visual field sensitivities at 52 points and analyzed differences between before and after surgery. We then compared the changes in visual field sensitivity between glaucomatous and normal hemifields. Next, we collected ERM eyes without glaucoma and stratified them into two groups based on axial length (threshold = 26.0 mm). In these eyes, we also recorded visual field sensitivities at 52 points and analyzed differences between before and after surgery. The study included 18 eyes with ERM and glaucoma with hemifield defect (11 men; mean age, 68.3 ± 7.2 years). These eyes showed significant sensitivity reductions at 5/26 points, mainly in the nasal area of the glaucomatous hemifield, whereas only 1/26 points exhibited significant sensitivity reduction in the normal hemifield. In eyes with axial length <26.0 mm and axial length ≥26.0 mm, 29 peripheral and seven superior peripheral points showed significant improvements in visual field sensitivities, respectively. Visual field sensitivity reduction occurred mainly in the nasal region of the glaucomatous hemifield. Differences in axial length alone were not a prominent risk factor for reduced visual field sensitivity after ILM peeling in eyes with ERM.

Identifiants

pubmed: 33534007
doi: 10.1007/s10384-021-00817-9
pii: 10.1007/s10384-021-00817-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

380-387

Subventions

Organisme : Grants-in-Aid for Scientific Research (C) from JSPS KAKENHI
ID : 19K09988

Références

Okamoto F, Okamoto Y, Hiraoka T, Oshika T. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life. Am J Ophthalmol. 2009;147:869–74.
doi: 10.1016/j.ajo.2008.11.018
Tanikawa A, Shimada Y, Horiguchi M. Comparison of visual acuity, metamorphopsia, and aniseikonia in patients with an idiopathic epiretinal membrane. Jpn J Ophthal. 2018;62:280–5.
doi: 10.1007/s10384-018-0581-x
Michels RG. Vitreous surgery for macular pucker. Am J Ophthalmol. 1981;92:628–39.
doi: 10.1016/S0002-9394(14)74654-9
Margherio RR, Cox MS Jr, Trese MT, Murphy PL, Johnson J, Minor LA. Removal of epimacular membranes. Ophthalmology. 1985;92:1075–83.
doi: 10.1016/S0161-6420(85)33902-7
Haas A, Seidel G, Steinbrugger I, Maier R, Gasser-Steiner V, Wedrich A, et al. Twenty-three-gauge and 20-gauge vitrectomy in epiretinal membrane surgery. Retina. 2010;30:112–6.
doi: 10.1097/IAE.0b013e3181b32ebf
Kim M, Park YS, Lee DH, Koh HJ, Lee SC, Kim SS. Comparison of surgical outcome of 23-gauge and 25-gauge microincision vitrectomy surgery for management of idiopathic epiretinal membrane in pseudophakic eyes. Retina. 2015;35:2115–20.
doi: 10.1097/IAE.0000000000000598
Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y, Yuzawa M. Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthalmology. 2009;116:1370–6.
doi: 10.1016/j.ophtha.2009.01.024
Schechet SA, DeVience E, Thompson JT. The effect of internal limiting membrane peeling on idiopathic epiretinal membrane surgery, with a review of the literature. Retina. 2017;37:873–80.
doi: 10.1097/IAE.0000000000001263
Chang WC, Lin C, Lee CH, Sung TL, Tung TH, Liu JH. Vitrectomy with or without internal limiting membrane peeling for idiopathic epiretinal membrane: a meta-analysis. PLoS ONE. 2017;12:e0179105.
doi: 10.1371/journal.pone.0179105
Diaz RI, Randolph JC, Sigler EJ, Calzada JI. Intraoperative grasp site correlation with morphologic changes in retinal nerve fiber layer after internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging Retina. 2014;45:45–9.
doi: 10.3928/23258160-20131220-06
Imamura Y, Ishida M. Retinal thinning after internal limiting membrane peeling for idiopathic macular hole. Jpn J Ophthalmol. 2018;62:158–62.
doi: 10.1007/s10384-018-0568-7
Scupola A, Grimaldi G, Abed E, Sammarco MG, Giudiceandrea A, Greco A, et al. Arcuate nerve fiber layer changes after internal limiting membrane peeling in idiopathic epiretinal membrane. Retina. 2018;38:1777–85.
doi: 10.1097/IAE.0000000000001768
Tsuchiya S, Higashide T, Sugiyama K. Visual field changes after vitrectomy with internal limiting membrane peeling for epiretinal membrane or macular hole in glaucomatous eyes. PLoS ONE. 2017;12:e0177526.
doi: 10.1371/journal.pone.0177526
Terashima H, Okamoto F, Hasebe H, Matsuoka N, Fukuchi T. Vitrectomy for epiretinal membranes: ganglion cell features correlate with visual function outcomes. Ophthalmol Retina. 2018;2:1152–62.
doi: 10.1016/j.oret.2018.04.020
Marcus MW, de Vries MM, Junoy Montolio FG, Jansonius NM. Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. Ophthalmology. 2011;118:1989–94.
doi: 10.1016/j.ophtha.2011.03.012
Chihara E, Liu X, Dong J, Takashima Y, Akimoto M, Hangai M, et al. Severe myopia as a risk factor for progressive visual field loss in primary open-angle glaucoma. Ophthalmologica. 1997;211:66–71.
doi: 10.1159/000310760
Chihara E. Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy. Jpn J Ophthalmol. 2014;58:16–25.
doi: 10.1007/s10384-013-0267-3
Asrani S, Essaid L, Alder BD, Santiago-Turla C. Artifacts in spectral-domain optical coherence tomography measurements in glaucoma. JAMA ophthalmol. 2014;132:396–402.
doi: 10.1001/jamaophthalmol.2013.7974
Sakimoto S, Okazaki T, Usui S, Ishibashi T, Oura Y, Nishida K, et al. Cross-sectional imaging analysis of epiretinal membrane involvement in unilateral open-angle glaucoma severity. Invest Ophthalmol Vis Sci. 2018;59:5745–51.
doi: 10.1167/iovs.18-25292
Takagi ST, Kita Y, Yagi F, Tomita G. Macular retinal ganglion cell complex damage in the apparently normal visual field of glaucomatous eyes with hemifield defects. J Glaucoma. 2012;21:318–25.
doi: 10.1097/IJG.0b013e31820d7e9d
Uchida N, Ishida K, Anraku A, Takeyama A, Tomita G. Macular vessel density in untreated normal tension glaucoma with a hemifield defect. Jpn J Ophthalmol. 2019;63:457–66.
doi: 10.1007/s10384-019-00691-6

Auteurs

Hiroki Kaneko (H)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. h-kaneko@med.nagoya-u.ac.jp.

Norifumi Hirata (N)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Kariya Toyota General Hospital, Kariya, Japan.

Hideyuki Shimizu (H)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Keiko Kataoka (K)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Norie Nonobe (N)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Kumiko Mokuno (K)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Kariya Toyota General Hospital, Kariya, Japan.

Hiroko Terasaki (H)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Institutes of Innovation for Future Society, Nagoya University, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH